DUBLIN--(BUSINESS WIRE)--The "Software as a Medical Device Market Analysis by Device (Smartphone, Desktop/Laptop, Wearable Devices), by Deployment (On-premise, Cloud-based), by Application (Clinical Management, Diagnostic), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The global software as a medical device (SaMD) market size is estimated to be USD 847.5 million in 2021 and is expected to witness a CAGR of 86.91% during the forecast period.
- Viz.ai Inc. (U.S.)
- Qlarity Imaging LLC (U.S.)
- Arterys Inc. (U.S.)
- iSchemaView Inc. (U.S.)
- Apple Inc. (U.S.)
- IDx Technologies Inc. (U.S.)
- Imagen Technologies (U.S.)
- MaxQ AI (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Siemens AG (Germany)
Increasing application of artificial intelligence in diagnostic of chronic illness is a key driver for the growth of the global software as a medical device market. Additionally, the rising geriatric population, growing demand for cost-effective quality healthcare services, and government support for the treatment of chronic diseases are some of the other drivers propelling the market growth.
However, the ambulatory regulatory policies and lack of awareness for technology are expected to restrain the global market growth.
Software As A Medical Device Market, By Device (Revenue, USD Million, 2021 - 2029)
- Wearable Devices
Software As A Medical Device Market, By Deployment (Revenue, USD Million, 2021 - 2029)
Software As A Medical Device Market, By Application (Revenue, USD Million, 2021 - 2029)
- Clinical Management
Software As A Medical Device Market, By Region (Revenue, USD Million, 2021 - 2029)
- Rest of Europe
- South Korea
- Rest of APAC
- Rest of LATAM
Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/74zrau